Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Fiyinfolu O. Balogun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4703-1560; OpenAlex author ID A5075614628. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
1
Labs led
0
Collaborators
45
Papers, trials and grants by year

2024: 1 paper, 1 grant · 2025: 3 papers · 2026: 6 papers

Papers 10

  1. Maximal Ablative Irradiation Because of Encasement for Patients With Locally Advanced Pancreatic Cancer: A Nonrandomized Clinical Trial. Co-author DOI 10.1001/jamasurg.2026.2988↗
  2. Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. Co-author DOI 10.1038/s41591-026-04299-5↗
  3. Pancreatic Cancer: Translating Tumor Biology into Actionability. Co-author DOI 10.1158/2159-8290.cd-25-2014↗
  4. Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report. Co-author DOI 10.21037/jgo-2025-aw-818↗
  5. POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer Co-author DOI 10.64898/2026.03.15.711961↗
  6. Neoantigen-reactive CD8 + T cell engagement marks exceptional survivors of pancreatic cancer Co-author DOI 10.64898/2026.09.17.752426↗
  7. Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Co-author DOI 10.1038/s41591-024-03362-3↗
  8. Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort. Co-author DOI 10.1093/jnci/djae269↗
  9. Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/jnci/djaf139↗
  10. Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease. Co-author DOI 10.1093/jnci/djae095↗

Grants 1

  1. LEAD Project Grant: Fiyinfolu Balogun AWARD lustgarten:2024-fiyinfolu-balogun-lead-project-grant-fiyinfolu-balogun

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wungki Park · 8 shared papers, 2024–2026 · strength 1.59
  2. Eileen Mary O'Reilly · 8 shared papers, 2024–2026 · strength 1.59
  3. Kenneth H. Yu · 8 shared papers, 2024–2026 · strength 1.56
  4. Anna M. Varghese · 6 shared papers, 2024–2026 · strength 1.11
  5. Marinela Capanu · 6 shared papers, 2024–2026 · strength 1.07
  6. Kevin C. Soares · 5 shared papers, 2025–2026 · strength 1.06
  7. Alice Chia-Chi Wei · 5 shared papers, 2025–2026 · strength 0.93
  8. Christine A. Iacobuzio–Donahue · 4 shared papers, 2025–2026 · strength 0.85
  9. Anupriya Singhal · 4 shared papers, 2024–2026 · strength 0.83
  10. Olca Baştürk · 4 shared papers, 2025–2026 · strength 0.81
  11. Vinod P. Balachandran · 4 shared papers, 2025–2026 · strength 0.76
  12. Fergus Keane · 4 shared papers, 2024–2026 · strength 0.72
  13. Marsha Reyngold · 3 shared papers, 2026 · strength 0.70
  14. William R. Jarnagin · 3 shared papers, 2025–2026 · strength 0.56
  15. Darren Cowzer · 3 shared papers, 2024–2025 · strength 0.53
  16. Mara H. Sherman · 2 shared papers, 2026 · strength 0.49
  17. Danny N. Khalil · 2 shared papers, 2026 · strength 0.40
  18. Michael Ian D'Angelica · 2 shared papers, 2025–2026 · strength 0.39
  19. Jeffrey A. Drebin · 2 shared papers, 2025–2026 · strength 0.39
  20. Christopher H. Crane · 2 shared papers, 2025–2026 · strength 0.39
  21. Benjamin D. Greenbaum · 2 shared papers, 2026 · strength 0.37
  22. Dana Pe'er · 2 shared papers, 2026 · strength 0.37
  23. Benoı̂t Rousseau · 2 shared papers, 2026 · strength 0.37
  24. Marc Hilmi · 2 shared papers, 2026 · strength 0.37
  25. Nuray Tezcan · 2 shared papers, 2026 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.